Study guide

2.3 Neonatal Jaundice & Hyperbilirubinemia

Arab Board Pediatrics Part 1 Written Examination ABHS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy

2 Neonatal Care I

2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia

3 Neonatal Care II

3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening

4 Infectious Diseases

4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections

5 Immunization

5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations

6 Allergy & Immunology

6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy

7 Growth & Development

7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders

8 Nutrition

8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)

9 Pediatric Emergencies I

9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology

10 Pediatric Emergencies II

10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding

11 Cardiology

11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease

12 Respiratory

12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders

13 Gastroenterology

13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia

14 Nephrology & Genitourinary

14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies

15 Hematology & Oncology

15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency

16 Endocrinology

16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty

17 Neurology

17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache

18 Genetics, Dysmorphology & Metabolism

18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism

19 Fluids, Electrolytes & Pharmacology

19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing

20 Dermatology, ENT, Ophthalmology & Musculoskeletal

20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders

21 Adolescent Medicine & Ethics

21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics

22 Final Review & Exam Strategy

22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management

2.3 Neonatal Jaundice & Hyperbilirubinemia

Key Takeaways Explain This Topic AI

Jaundice appearing within the first 24 hours of life is never physiologic and always requires urgent evaluation for hemolysis, infection, or another pathologic cause.

Conjugated bilirubin above 1 mg/dL, or more than 20% of the total, is never physiologic and demands prompt investigation, since biliary atresia outcomes worsen sharply after 8 weeks of age.

ABO hemolytic disease can occur in a first pregnancy because anti-A and anti-B antibodies are naturally occurring, unlike Rh disease, which requires prior maternal sensitization; ABO disease is usually milder.

Phototherapy and exchange transfusion thresholds are read from hour-specific bilirubin nomograms stratified by gestational age and neurotoxicity risk factors, not from one fixed number for every infant.

The chronic kernicterus tetrad is choreoathetoid cerebral palsy, upward gaze palsy, sensorineural hearing loss, and dental enamel dysplasia.

Last updated: July 2026

Physiologic vs. Pathologic Jaundice

Neonatal jaundice , yellow discoloration of skin and sclera from bilirubin deposition, affects the majority of newborns to some degree and is usually unconjugated (indirect) hyperbilirubinemia arising from an immature hepatic conjugation pathway combined with a high neonatal red cell turnover. Physiologic jaundice typically appears after 24 hours of age, peaks around day 3-5 (day 5-7 in preterm infants) at a total serum bilirubin generally below 12-15 mg/dL, and resolves within 1-2 weeks. Pathologic jaundice is suggested by several exam-favorite red flags: jaundice appearing within the first 24 hours of life, a total bilirubin rising faster than expected (more than about 5 mg/dL per day, or crossing percentile lines on a standardized nomogram), a total bilirubin above the phototherapy threshold for the infant's age, or any elevation in conjugated (direct) bilirubin above 1 mg/dL or more than 20% of the total. Jaundice within the first 24 hours of life is never physiologic and always warrants urgent evaluation for hemolysis or infection.

Unconjugated vs. Conjugated Hyperbilirubinemia

Distinguishing unconjugated from conjugated hyperbilirubinemia focuses the differential diagnosis:

Type Mechanism Common Causes

Unconjugated (indirect) Overproduction or under-conjugation Physiologic jaundice, ABO/Rh hemolytic disease, G6PD deficiency, hereditary spherocytosis, cephalohematoma or bruising, polycythemia, Crigler-Najjar or Gilbert syndrome, breastfeeding/breast-milk jaundice, hypothyroidism

Conjugated (direct) Impaired excretion/cholestasis Biliary atresia, neonatal hepatitis, TORCH infections, alpha-1 antitrypsin deficiency, choledochal cyst, parenteral-nutrition-associated cholestasis, metabolic disease such as galactosemia

Conjugated hyperbilirubinemia is never physiologic and always requires prompt investigation — biliary atresia in particular is time-sensitive, since surgical outcomes with the Kasai portoenterostomy worsen sharply after 8 weeks of age. On examination, infants with conjugated hyperbilirubinemia often have dark urine and acholic (pale) stools , whereas unconjugated jaundice produces colorless urine and normally pigmented stools — a high-yield bedside clue to cholestasis that should trigger urgent hepatobiliary workup.

ABO and Rh Hemolytic Disease

Rh hemolytic disease occurs when an Rh-negative mother is sensitized to Rh-positive fetal red cells (typically from a prior pregnancy or bleed) and produces IgG anti-D antibodies that cross the placenta and hemolyze fetal or neonatal red cells; it can cause severe anemia and hydrops fetalis, and is now largely prevented by giving anti-D immunoglobulin to Rh-negative mothers at around 28 weeks gestation and again after delivery of an Rh-positive infant. ABO hemolytic disease occurs when a type O mother carries a type A or type B fetus. Unlike Rh disease, it can occur in a first pregnancy , because naturally occurring anti-A and anti-B IgG requires no prior sensitization, but it is usually milder, since A and B antigens are less densely expressed on fetal red cells. Both are evaluated with a direct antiglobulin (Coombs) test , evidence of hemolysis such as an elevated reticulocyte count or spherocytes on smear, and early-onset jaundice. G6PD deficiency , an X-linked enzymopathy common in Mediterranean, Middle Eastern, and African populations, can trigger acute hemolysis after oxidative stress (infection, certain drugs, or fava beans) and is a key cause of pathologic jaundice in male newborns that the Arab Board frequently tests.

Breastfeeding Jaundice vs. Breast-Milk Jaundice

These two entities are a classic exam discriminator:

  • Feature Breastfeeding Jaundice Breast-Milk Jaundice
  • Onset Days 2-4 After day 5-7

Mechanism Insufficient milk intake reduces stooling, increasing enterohepatic recirculation of bilirubin Substances in breast milk increase enterohepatic bilirubin recirculation

Peak/duration First week Can persist 3-12 weeks

Management Improve feeding frequency and technique, lactation support; avoid unnecessary formula supplementation Usually reassurance and continued breastfeeding; interrupting breastfeeding is rarely necessary

The exam trap: breastfeeding itself should essentially never be stopped for either condition — supporting effective, continued breastfeeding is the correct answer far more often than "discontinue breastfeeding."

Bilirubin Nomograms and Phototherapy Thresholds

Management decisions use hour-specific total serum or transcutaneous bilirubin nomograms — the Bhutani nomogram for predischarge risk-of-progression screening, and current phototherapy and exchange-transfusion threshold curves — that plot bilirubin against postnatal age in hours, stratified by gestational age and the presence of neurotoxicity risk factors such as isoimmune hemolytic disease, G6PD deficiency, sepsis, significant lethargy, temperature instability, or a low serum albumin. Lower gestational age and the presence of risk factors both lower the treatment threshold substantially, so a 35-week infant with a risk factor is treated at a much lower bilirubin level than a healthy 40-week infant at the same postnatal age. As a general orientation rather than a substitute for reading the actual nomogram, phototherapy thresholds for a healthy term infant without risk factors are roughly in the 12-15 mg/dL range on day 1, rising to roughly 18-20 mg/dL by day 3-4, while a preterm or risk-factor-positive infant is treated several mg/dL lower at the same postnatal age.

Exchange Transfusion

Exchange transfusion is reserved for bilirubin levels that remain markedly elevated despite intensive phototherapy — roughly 4-5 mg/dL above the phototherapy threshold, or approaching levels associated with neurotoxicity — or for infants presenting with signs of acute bilirubin encephalopathy at any bilirubin level. When the total bilirubin comes within 2 mg/dL of the exchange threshold, this is treated as a medical emergency: the infant is escalated to intensive phototherapy with maximum irradiance and prepared for possible exchange. Exchange transfusion mechanically removes bilirubin and antibody-coated red cells far faster than phototherapy alone, which is particularly important in severe isoimmune hemolytic disease.

Kernicterus and Bilirubin Encephalopathy

Kernicterus , chronic and permanent bilirubin encephalopathy, results from deposition of unconjugated bilirubin in the basal ganglia and brainstem nuclei once bilirubin crosses the blood-brain barrier, typically at very high, prolonged unconjugated bilirubin levels (conjugated bilirubin is not neurotoxic in this way). Acute bilirubin encephalopathy presents in phases: early lethargy and poor feeding, progressing to hypertonia with retrocollis-opisthotonos and a high-pitched cry, and, if untreated, seizures and coma. Survivors of severe encephalopathy develop the classic chronic kernicterus tetrad: choreoathetoid cerebral palsy, upward gaze palsy, sensorineural hearing loss, and dental enamel dysplasia . Because kernicterus is largely preventable, the exam consistently rewards early recognition of risk factors — early-onset jaundice, hemolysis, prematurity — and timely phototherapy or exchange transfusion over delayed intervention.